Invention Grant
- Patent Title: Substituted bicyclic heteroaryl compounds
- Patent Title (中): 取代的双环杂芳基化合物
-
Application No.: US14598721Application Date: 2015-01-16
-
Publication No.: US09242967B2Publication Date: 2016-01-26
- Inventor: Upender Velaparthi , Peiying Liu
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Gary D. Greenblatt
- Main IPC: C07D413/00
- IPC: C07D413/00 ; C07D333/00 ; C07D409/14 ; C07D498/04 ; C07D413/14 ; C07D409/04 ; C07D413/04 ; C07D487/04 ; C07D417/14 ; C07D471/04 ; C07D495/04 ; C07D519/00 ; C07D413/06
Abstract:
Disclosed are azaindazole compounds of Formula (I): or a pharmaceutically acceptable salt thereof, wherein: X is O and Y is N; or X is S and Y is CH; Z is CR2 or N; Q is a heteroaryl; and R1 is defined herein. Also disclosed are methods of using such compounds in the treatment of at least one CYP17 assoC1ated condition, such as, for example, cancer, and pharmaceutical compositions comprising such compounds.
Public/Granted literature
- US20150126529A1 SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS Public/Granted day:2015-05-07
Information query
